Skip to Content

WW 74 (Letrozole 2.5 mg)

Pill with imprint WW 74 is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by Arab Pharmaceutical Manufacturing Co. PSC Ltd.

Letrozole is used in the treatment of female infertility; breast cancer, metastatic; breast cancer; breast cancer, adjuvant and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WW 74

Letrozole

Imprint:
WW 74
Strength:
2.5 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Aromatase inhibitors
Hormones/antineoplastics
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Arab Pharmaceutical Manufacturing Co. PSC Ltd
National Drug Code (NDC):
24535-0801

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide